Tampon suppliers and shoppers have grappled with the strain for weeks, according to The Washington Post and The New York Times.
So far this year, two key ingredients for tampons are facing steep inflated prices, with plastic surging 9.5 percent and cotton 40 percent.
Procter & Gamble, which manufactures Tampax, said it is more difficult to acquire these materials after a nearly 8 percent hike in sales since 2020. Andre Schulten, P&G’s CFO, said on a recent earnings call that the situation is “costly and highly volatile,” according to the Times.
With a shorter supply of the menstrual product, the cost for a box of tampons rose 10 percent this past year, according to the Post.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.